arrow
T

Toni Cathomen

medical center university of freiburg
H指数:52
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeted insertion of an optimized donor DNA is effective in a humanized mouse model of dominant retinitis pigmentosa

在显性色素性视网膜变性的人源化小鼠模型中,靶向插入优化的供体DNA是有效的

2026-09-110
OAAI
Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation

他克莫司抵抗性调节性T细胞的临床开发以实现同时免疫抑制和免疫调节

2026-05-012
OAAI
ERCC6L2 ensures repair fidelity for staggered-end DNA double-strand breaks

ERCC6L2 确保错位末端DNA双链断裂的修复保真度

2026-02-250
OAAI
Base edited skin equivalents with clinical potential for ex vivo correction of Recessive Dystrophic Epidermolysis Bullosa

具有临床潜力的碱基编辑皮肤替代物,用于体外修复隐性营养不良型大疱性表皮松解症

2025-11-170
PRE
Targeted Inhibition of ELANE Expression Using Adenine Base Editing to Treat Severe Congenital Neutropenia

利用腺嘌呤碱基编辑靶向抑制ELANE表达以治疗重症先天性中性粒细胞减少症

2025-11-050
OAAI
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa

连接性表皮松解症的潜在治疗策略:碱基编辑

2025-10-300
OAAI
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease

靶向基因编辑和近全基因组cDNA插入CYBA和CYBB作为慢性肉芽肿病的治疗方法

2025-08-120
OAAI
Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6-mediated gene editing in hematopoietic stem cells

衰老和炎症是CRISPR-Cas9/AAV6介导的造血干细胞基因编辑的非预期不良后果。

2025-06-030
OA
Donor insertion into CX3CR1 allows epigenetic modulation of a constitutive promoter on hematopoietic stem cells and its activation upon myeloid differentiation

供体插入CX3CR1中允许对造血干细胞中组成型启动子进行表观遗传调控,并在髓系分化时激活该启动子。

2025-04-290
OA
Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transfer

CD3 epsilon基因编辑以重定向调节性T细胞用于过继性T细胞转移

2025-02-011
OAAI
Genome editing with the HDR-enhancing DNA-PKcs inhibitor AZD7648 causes large-scale genomic alterations

使用增强HDR的dna-pkcs抑制剂AZD7648进行基因组编辑会导致大规模的基因组改变

2024-11-270
OA
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
2024-09-303
OAAI